Abstract
Probiotics are often referred to as microorganisms (bacteria or yeasts) that generally provide health benefits. There is great interest in probiotics for various medical reasons and millions of people around the world consume probiotic microorganisms daily with the perception that it is beneficial for health. Members of the genus Lactococcus and Lactobacillus, Streptococcus, Enterococcus strains, and some other LAB strains are generally accepted as safe (GRAS) status, although they contain some opportunistic pathogens. In addition, some of the spore forming bacteria have been researched and used as probiotics. However, nowadays theoretical concerns and side effects are discussed with regard to the safety of probiotics. Systemic infections, the risk of harmful metabolic activities, risk of adjuvant side effects, immunomodulation and gene transfer risk are among the theoretical concerns discussed. The most common side effects of probiotic microorganisms include gastrointestinal disorders such as nausea, diarrhea, bloating, abdominal pain and dyspepsia. Other side effects include respiratory tract infections, abscess, allergic reactions and severe medical conditions such as sepsis, endocarditis and fungemia. The safety of probiotics is related to the potential vulnerability of the consumer or the patient, the dose of use, duration of consumption and the frequency of consumption. The significance of negative probiotic effects will be better understood by understanding of the probiotic interaction mechanisms with host and colonizing microbes. In this chapter, the evaluation of the risk associated with the consumption of probiotic products has been discussed, based on epidemiological data and infected cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aakra Å, Nyquist L, Snipen L et al (2007) Survey of genomic diversity among Enterococcus faecalis strains by microarray-based comparative genomic hybridisation. Appl Environ Microbiol 73(7):2207–2217
Abriouel H, Benomar N, Molinos AC et al (2008) Comparative analysis of genetic diversity and incidence of virulence factors and antibiotic resistance among enterococcal populations from raw fruit and vegetable foods, water, soil, and clinical samples. Int J Food Microbiol 123(1-2):38–49
Adams MR, Marteau P (1995) On the safety of lactic acid bacteria from food. Int J Food Microbiol 27(2-3):263–264
Ahn C, Collins-Thompson D, Duncan C et al (1992) Mobilization and location of the genetic determinant of chloramphenicol resistance from Lactobacillus plantarum caTC2R. Plasmid 27(3):169–176
Ammor MS, Florez AB, Mayo B (2007) Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol 24(6):559–570
Antony S, Stratton CW, Dummer JS (1996) Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis 23(4):773–778
Asahara T, Takahashi M, Nomoto K et al (2003) Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol 10(1):169–173
Bassetti S, Frei R, Zimmerli W (1998) Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. Am J Med 105(1):71–72
Berg RD, Garlington AW (1979) Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in the gnotobiotic Mouse model. Infect Immun 23(2):403–411
Bongaerts G, Bakkeren J, Severijnen R et al (2000) Lactobacilli and acidosis in children with short small bowel. J Pediatr Gastroenterol Nutr 30(3):288–293
Borriello SP, Hammes WP, Holzapfel W et al (2003) Safety of probiotics that contain lactobacilli or bifidobacterial. Clin Infect Dis 36(6):775–780
Boyle RJ, Robins-Browne RM, Tang ML (2006) Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83(6):1256–1264
Bozkurt H, Aslım B (2004) İmmobilizasyonun Probiyotik Kültürlerde Kullanımı. Orlab On-Line Mikrobiyoloji Dergisi 2(7):01–14
Cannon JP, Lee TA, Bolanos JT et al (2005) Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 24(1):31–40
Cassone M, Serra P, Mondello F et al (2003) Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol 41(11):5340–5343
Cesaro S, Chinello P, Rossi L et al (2000) Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 8(6):504–505
Ceyhan N, Alıç H (2012) Bağırsak Mikroflorası ve Probiyotikler. Türk Bilimsel Derlemeler Dergisi 5(1):107–113
Ciffo F (1984) Determination of the spectrum of antibiotic resistance of the Bacillus subtilis strains of Enterogermina. Chemioterapia 3(1):45–52
Clancy R (2003) Immunobiotics and the probiotic evolution. FEMS Immunol Med Microbiol 38(1):9–12
Connolly E, Abrahamsson T, Bjorksten B (2005) Safety of D(-)-lactic acid producing bacteria in the human infant. J Pediatr Gastroenterol Nutr 41(4):489–492
Çoşkun T (2006) Pro-, Pre- ve Sinbiyotikler. Çocuk Sağlığı ve Hastalıkları Dergisi 49(2):128–148
Cunningham-Rundles S, Ahrné S, Bengmark S et al (2000) Probiotics and immune response. Am J Gastroenterol 95(1):S22–S25
De Boer AS, Diderichsen B (1991) On the safety of Bacillus subtilis and B. amyloliquefaciens: a review. Appl Microbiol Biotechnol 36:1–4
De Groote MA, Frank DN, Dowell E et al (2005) Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 24(3):278–280
Dessart SR, Steenson LR (1991) High frequency intergeneric and intrageneric conjugal transfer of drug resistance plasmids in Leuconostoc mesenteroides ssp. cremoris. J Dairy Sci 74(9):2912–2919
Dewan S, Tamang JP (2007) Dominant lactic acid bacteria and their technological properties isolated from the himalayan ethnic fermented milk products. Antonie Van Leeuwenhoek 92(3):343–352
Domann E, Hain T, Ghai R et al (2007) Comparative genomic analysis for the presence of potential enterococcal virulence factors in the probiotic Enterococcus faecalis strain Symbioflor 1. Int J Med Microbiol 297(7-8):533–539
Donohue DC, Salminen S (1996) Safety of probiotic bacteria. Asia Pac J Clin Nutr 5:25–28
Duc LH, Dong TC, Logan NA et al (2005) Cases of emesis associated with bacterial contamination of an infant breakfast cereal product. Int J Food Microbiol 102(2):245–251
Duffy LC (2000) Interactions mediating bacterial translocation in the immature intestine. J Nutr 130(2):432–436
Eaton TJ, Gasson MJ (2001) Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol 67(4):1628–1635
Ebners S, Smug LN, Kneifel W et al (2014) Probiotics in dietary guidelines and clinical recommendations outside the European Union. World J Gastroenterol 20(43):16095–16100
FAO/WHO (2001) Food and Agriculture Organization/World Health Organization. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available from http://www.fao.org/es/ESN/food/foodandfood_probio_en.stm. Accessed 1 July 2003
FAO/WHO. (2002) Food and Agriculture Organization/World Health Organization. Guidelines for the evaluation of probiotics in foods, report of a joint FAO/WHO working group, London, Ontario, Canada, April 30 and May 1 2002. Available from ftp://ftp.fao.org/es/esn/food/wgreport2.pdf
Franz CMAP, Muscholl-Silberhorn AB, Yousif NMK (2001) Incidence of virulence factors and antibiotic resistance among enterococci isolated from food. Appl Environ Microbiol 67(9):4385–4389
Fredenucci I, Chomarat M, Boucaud C et al (1998) Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clin Infect Dis 27(1):222–223
Friedman G (2005) Probiotics, prebiotics, and commensal bacteria: perspectives and clinical applications in gastroenterology. Gastroenterol Clin North Am 34(3):13–16
From C, Pukall R, Schumann P et al (2005) Toxin-producing ability among Bacillus spp. outside the Bacillus cereus group. Appl Environ Microbiol 71(3):1178–1183
Gallemore GH, Mohon RT, Ferguson DA (1995) Lactobacillus fermentum endocarditis involving a native mitral valve. J Tenn Med Assoc 88(8):306–308
Gasser F (1994) Safety of lactic-acid bacteria and their occurrence in human clinical infections. Bull Inst Pasteur 92:45–67
Gevers D, Danielsen M, Huys G et al (2003) Molecular characterization of tet(M) genes in Lactobacillus isolates from different types of fermented dry sausage. Appl Environ Microbiol 69(2):1270–1275
Gismondo MR, Drago L, Lombardi A (1999) Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents 12(4):287–292
Gönülateş N (2008) Kefirin insanlar üzerindeki immünomodülatör etkilerinin araştırılması. (Doctoral dissertation, SDÜ Tıp Fakültesi)
Granum PE (2002) Bacillus cereus and food poisoning. In: Berkeley R, Heyndrickx M, Logan NA, de Vos P (eds) Applications and systematics of bacillus and relatives. Blackwell Science, Oxford, pp 37–46
Granum PE, Lund T (1997) Bacillus cereus and its food poisoning toxins. FEMS Microbiol Lett 157(2):223–228
Green DH, Wakeley PR, Page A et al (1999) Characterization of two Bacillus probiotics. Appl Environ Microbiol 65(9):4288–4291
Guarner F, Schaafsma GJ (1998) Probiotics. Int J Food Microbiol 39(3):237–238
Guinebretiere MH, Broussolle V, Nguyen-The C (2002) Enterotoxigenic profiles of food-poisoning and food borne Bacillus cereus strains. J Clin Microbiol 40:3053–3056
Gülmez M, Güven A (2002) Probiyotik prebiyotik ve sinbiyotikler. Kafkas Üniversitesi Veteriner Fakültesi Dergisi 8:83–89
Hennequin C, Kauffmann-Lacroix C, Jobert A et al (2000) Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis 19(1):16–20
Henriksson A, Borody T, Clancy R (2005) Probiotics under the regulatory microscope. Expert Opin Drug Saf 4(6):1135–1143
Herreros MA, Sandoval H, González L et al (2005) Antimicrobial activity and antibiotic resistance of lactic acid bacteria isolated from Armada cheese (a Spanish goats’ milk cheese). Food Microbiol 22(5):455–459
Hong HA, Duc LH, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29(4):813–835
Huang Y, Kotula L, Adams MC (2003) The in-vivo assessment of safety and gastrointestinal survival of an orally administered novel probiotic, Propionibacterium jensenii 702, in a male Wistar rat model. Food Chem Toxicol 41(12):1781–1787
Husni RN, Gordon SM, Washington JA et al (1997) Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 25(5):1048–1055
Ishibashi N, Yamazaki S (2001) Probiotics and safety. Am J Clin Nutr 73(2):465–470
Johnson AP (1994) The pathogenicity of enterococci. Int J Antimicrob Agents 33(6):1083–1089
Kalima P, Masterton RG, Roddie PH (1996) Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect 32(2):165–167
Kayser FH (2003) Safety aspects of enterococci from the medical point of view. Int J Food Microbiol 88(2-3):255–262
Klein G, Hallmann C, Casas IA (2000) Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. J Appl Microbiol 89:815–824
Koehler TM, Thorne CB (1987) Bacillus subtilis (natto) plasmid pLS20 mediates interspecies plasmid transfer. J Bacteriol 169(11):5271–5278
Kramer JM, Turnbull PCB, Munshi G et al (1982) Identification and characterization of Bacillus cereus and other Bacillus species associated with foods and food poisoning. In: Corry JEL, Roberts D, And Skinner FA (eds) Isolation and identification methods for food poisoning organisms. Academic Press, London, pp 261–286
Kunz AN, Noel JM, Fairchok MP (2004) Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 38(4):457–458
Land MH, Rouster-Stevens K, Woods CR et al (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115(1):178–181
Landman D, Quale JM (1997) Management of infections due to resistant enterococci: a review of therapeutic options. J Antimicrob Chemother 40:161–170
Leclercq R (1997) Enterococci acquire new kinds of resistance. Clin Infect Dis 24(Suppl.1):80–84
Lee YK, Salminen S (2009) Handbook of probiotics and prebiotics. John Wiley & Sons, New York
Lepage E, Brinster S, Caroin C et al (2006) Comparative genomic hybridization analysis of Enterococcus faecalis: identification of genes absent from food strains. J Bacteriol 188(9):6858–6868
Lherm T, Monet C, Nougiere B et al (2002) Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 28(6):797–801
Lin CF, Fung ZF, Wu CL et al (1996) Molecular characterization of a plasmid-borne (pTC82) chloramphenicol resistance determinant (cat-TC) from Lactobacillus reuteri G4. Plasmid 36(2):116–124
Liong MT, Shah NP (2005) Bile salt deconjugation and BSH activity of five bifidobacterial strains and their cholesterol co-precipitating properties. Food Res Int 38(2):135–142
Logan NA (2004) Safety of aerobic endospore-forming bacteria. In: Ricca E, Henriques AO, Cutting SM (eds) Bacterial spore formers: probiotics and emerging applications. Horizon Bioscience, Norfolk, pp 93–106
Maragkoudakis PA, Zoumpopoulou G, Miaris C et al (2006) Probiotic potential of Lactobacillus strains isolated from dairy products. Int Dairy J 16(3):189–199
Marteau P, Pochart P, Flourie B et al (1990) Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 52(4):685–688
Martin-Platero AM, Maqueda M, Valdivia E et al (2009) Polyphasic study of microbial communities of two Spanish farmhouse goats’ milk cheeses from Sierra de Aracena. Food Microbiol 26(3):294–304
Mathur S, Singh R (2005) Antibiotic resistance in food lactic acid bacteria-a review. Int J Food Microbiol 105(3):281–295
Mazza P, Zani F, Martelli P (1992) Studies on the antibiotic resistance of Bacillus subtilis strains used in oral bacteriotherapy. Boll Chim Farm 131(11):401–408
McBride SM, Fischetti VA, LeBlanc DJ et al (2007) Genetic diversity among Enterococcus faecalis. PLoS One 2(7):e582
McGowan-Spicer LL, Fedorka-Cray PJ, Frye JG et al (2008) Antimicrobial resistance and virulence of Enterococcus faecalis isolated from retail food. J Food Prot 71(4):760–769
McNaught CE, Woodcock NP, MacFie J et al (2002) A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 51:827–831
Metchnikoff II (2004) The prolongation of life: optimistic studies. Springer Publishing Company, New York
Morrison D, Woodford N, Cookson B (1997) Enterococci as emerging pathogens of humans. J Appl Microbiol Symp Suppl 83:89–99
Muñoz-Atienza E, Gómez-Sala B, Araújo C et al (2013) Antimicrobial activity, antibiotic susceptibility and virulence factors of lactic acid bacteria of aquatic origin intended for use as probiotics in aquaculture. BMC Microbiol 13(1):15
Murray BE (1990) The life and times of the Enterococcus. Clin Microbiol Rev 3(1):46–65
Murray PR, Baron E, Jorgenson JH et al (2003) Manual of clinical microbiology. ASM Press, Washington, pp 857–869
O’Brien J, Crittenden R, Ouwehand AC et al (1999) Safety evaluation of probiotics. Trends Food Sci Technol 10:418–424
Oggioni MR, Pozzi G, Valensin PE et al (1998) Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis. J Clin Microbiol 36(1):325–326
Olano A, Chua J, Schroeder S et al (2001) Weissella confusa (Basonym: Lactobacillus confusus) bacteremia: a case report. J Clin Microbiol 39(4):1604–1607
Osipova IG, Sorokulova IB, Tereshkina NV et al (1998) Safety of bacteria of the genus Bacillus, forming the base of some probiotics. Zh Mikrobiol Epidemiol Immunobiol 6:68–70
Otles S, Cagindi O (2003) Kefir: a probiotic dairy-composition, nutritional and therapeutic aspects. Pak J Nutr 2(2):54–59
Ouoba LII, Lei V, Jensen LB (2008) Resistance of potential probiotic lactic acid bacteria and Bifidobacteria of African and European origin to nantimicrobials: determination and transferability of the resistance genes to other bacteria. Int J Food Microbiol 121(2):217–224
Ouwehand AC, Saxelin M, Salminen S (2004) Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis 39(12):1858–1860
Özden A (2005) Gastrointestinal sistem ve probiyotik-prebiyotik-sinbiyotik. Güncel Gastroenteroloji 9(3):124–133
Özteber M (2013) Fermente süt ürünlerinden izole edilen laktik asit bakterilerinin antibiyotik dirençliliklerinin fenotipik ve genotipik yöntemlerle belirlenmesi. Master’s thesis, Adnan Menderes Üniversitesi, Fen Bilimleri Enstitüsü
Patel R, Cockerill FR, Porayko MK et al (1994) Lactobacillemia in liver transplant patients. Clin Infect Dis 18:207–212
Perapoch J, Planes AM, Querol A et al (2000) Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur J Clin Microbiol Infect Dis 19(6):468–470
Perdigon G, Alvarez S, Aquero G et al (1997) Interactions between lactic acid bacteria, intestinal microflora and the immune system. In: Martins MT, Zanoli Sato MI, Tiedje JM, Norton Haggler JB, Dobereiner J, Sanchez P (eds) Proceedings of the 7th International Symposium of Microbial Ecology, Santos, Brazil, pp 311–316
Pérez-Pulido R, Abriouel H, Ben Omar N et al (2006) Safety and potential risks of enterococci isolated from traditional fermented capers. Food Chem Toxicol 44(12):2070–2077
Phelps RJ, McKillip JL (2002) Enterotoxin production in natural isolates of Bacillaceae outside the Bacillus cereus group. Appl Environ Microbiol 68(6):3147–3151
Przyrembel H (2001) Consideration of possible legislation within existing regulatory frameworks. Am J Clin Nutr 73(2):471–475
Ranadheera CS, Evans CA, Adams MC (2014) Effect of dairy probiotic combinations on in vitro gastrointestinal tolerance, intestinal epithelial cell adhesion and cytokine secretion. J Funct Foods 8:18–25
Rautio M, Jousimies-Somer H, Kauma H et al (1999) Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28(5):1159–1160
Reid G (2002) Safety of lactobacillus strains as probiotic agents. Clin Infect Dis 35(3):349–350
Richard V, Van der Auwera P, Snoeck R et al (1988) Nosocomial bacteremia caused by Bacillus species. Eur J Clin Microbiol Infect Dis 7(6):783–785
Rodriguez AV, Baigorí MD, Alvarez S et al (2001) Phosphatidylinositol-specific phospholipase C activity in Lactobacillus rhamnosus with capacity to translocate. FEMS Microbiol Lett 204(1):33–38
Rowan NJ, Deans K, Anderson JG et al (2001) Putative virulence factor expression by clinical and food isolates of Bacillus spp. after growth in reconstituted infant milk formulae. Appl Environ Microbiol 67(9):3873–3881
Ruiz-Garbajosa P, Bonten MJ, Robinson DA et al (2006) Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of evolution. J Clin Microbiol 44(6):2220–2228
Ruseler-van Embden JG, van Lieshout LM, Gosselink MJ et al (1995) Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. Scand J Gastroenterol 30(7):675–680
Saarela M, Mogensen G, Fonden R (2000) Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84(3):197–215
Sağdıç O, Küçüköner E, Özçelik S (2004) Probiyotik ve Prebiyotiklerin Fonksiyonel Özellikleri, Atatürk Üniv. Ziraat Fak Dergisi 35(3-4):221–228
Salminen MK (2006) Lactobacillus bacteremia, with special focus on the safety of probiotic Lactobacillus rhamnosus GG (doctoral dissertation). University of Helsinki, Helsinki
Salminen S, von Wright A, Morelli L et al (1998) Demonstration of safety of probiotics – a review. Int J Food Microbiol 44(1-2):93–106
Salminen MK, Tynkkynen S, Rautelin H et al (2002) Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35(10):1155–1160
Salminen MK, Rautelin H, Tynkkynen S et al (2004) Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 38(1):62–69
Salyers AA, Gupta A, Wang Y (2004) Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 12(9):412–416
Sanders ME, Morelli L, Tompkins TA (2003) Sporeformers as human probiotics: bacillus, sporolactobacillus, and brevibacillus. Compr Rev Food Sci Food Saf 2(3):101–110
Saxelin M, Chuang NH, Chassy B (1996) Lactobacilli and bacteremia in southern Finland, 1989–1992. Clin Infect Dis 22(3):564–566
SCAN (2002a) Scientific Committee on Animal Nutrition. Report of the Scientific Committee on Animal Nutrition. Opinion of the Scientific Committee on Animal Nutrition on the safety of use of Bacillus species in animal nutrition. European Commission, Health & Consumer Protection Directorate-General, Brussels
SCAN (2002b) Scientific Committee on Animal Nutrition. Report of the Scientific Committee on Animal Nutrition, Opinion of the SCAN on the criteria for assessing the safety of microorganisms resistant to antibiotics of human, clinical, and veterinary importance. European Commission Health & Consumer Protection Directorate-General, Brussels. http://europa.eu.int/comm/food/fs/sc/scan/out64_en.pdf. Accesses 1 July 2003
Senok AC, Ismaeel AY, Botta GA (2005) Probiotics: facts and myths. Clin Microbiol Infect 11(12):958–966
Serio A, Paparella A, Chaves-López C (2007) Enterococcus populations in Pecorino Abruzzese cheese: biodiversity and safety aspects. J Food Prot 70(7):1561–1568
Shortt C (1999) The probiotic century: historical and current perspectives. Trends Food Sci Technol 10(12):411–417
Shu Q, Zhou JS, Rutherfurd KJ (1999) Probiotic lactic acid bacteria (Lactobacillus acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019) have no adverse effects on health of mice. Int Dairy J 9(11):831–836
Solheim M, Brekke MC, Snipen LG (2011) Comparative genomic analysis reveals significant enrichment of mobile genetic elements and genes encoding surface-structure proteins in hospital-associated clonal-complex 2 Enterococcus faecalis. BMC Microbiol 11(1):3
Spinosa MR, Wallet F, Courcol RJ (2000) The trouble in tracing opportunistic pathogens: cholangitis due to Bacillus in a French hospital caused by a strain related to an Italian probiotic? Microb Ecol Health Dis 12(2):99–101
Sullivan A, Nord CE (2006) Probiotic lactobacilli and bacteraemia in Stockholm. Scand J Infect Dis 38(5):327–331
Snydman, D. R. (2008). The safety of probiotics. Clinical infectious diseases, 46(Supplement_2), S104–S111.
Tall BD (2016) We are what we eat: should food microbiology take the lead on understanding how the homeostasis of the gut microbiome influences human health and disease? IAFP Annual Meeting, Des Moines
Timmerman HM, Koning CJM, Mulder L (2004) Monostrain, multistrain and multispecies probiotics - a comparison of functionality and efficacy. Int J Food Microbiol 96(3):219–233
Toprak Kavas S (2007) Probiyotik Mikroorganizmaların Gastrointestinal Sistem Uyumluluğu Ve Enterik Patojenlere Etkisi. Pamukkale Üniversitesi Tıp Fakültesi İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Uzmanlık Alan Tezi
Tynkkynen S, Singh KV, Varmanen P (1998) Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol 41(3):195–204
Valenzuela AS, Omar NB, Abriouel H (2008) Risk factors in enterococci isolated from foods in Morocco: determination of antimicrobial resistance and incidence of virulence traits. Food Chem Toxicol 46(8):2648–2652
Veltrop MHAM, Bancsi MJLM, Bertina RM et al (2000) Role of monocytes in experimental Staphylococcus aureus endocarditis. Infect Immun 68(8):4818–4821
Vergis EN, Hayden MK, Chow JW et al (2001) Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 135(7):484–492
Wassenaar TM, Klein G (2008) Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. J Food Prot 71(8):1734–1741
Werner G, Coque TM, Hammerum AM et al (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Eurosurveillance 13(47):1–11
Wheeler RT, Kupiec M, Magnelli P et al (2003) A Saccharomyces cerevisiae mutant with increased virulence. Proc Natl Acad Sci U S A 100(5):2766–2770
Willems RJ, Homan W, Top J (2001) Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357(9259):853–855
Wolf BW, Wheeler KB, Ataya DG (1998) Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol 36(12):1085–1094
Yiğit T (2009) Süt ve Süt Ürünlerinden Probiyotik Bakterilerden İzolasyonu. Anadolu Üniversitesi,Yüksek Lisans Tezi, Eskişehir
Yousif NM, Dawyndt P, Abriouel H (2005) Molecular characterization, technological properties and safety aspects of enterococci from ‘Hussuwa’, an African fermented sorghum product. J Appl Microbiol 98(1):216–228
Yuksekdag ZN, Aslim B (2010) Assessment of potential probiotic-and starter properties of Pediococcus spp. isolated from Turkish-type fermented sausages (sucuk). J Microbiol Biotechnol 20(1):161–168
Zhou JS, Shu Q, Ritherford KJ et al (2000a) Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol 38(2-3):153–161
Zhou JS, Shu Q, Rutherfurd KJ et al (2000b) Safety assessment of potential probiotic lactic acid bacteria strains Lactobacillus rhamnosus HN001, Lb. Acidophilus HN017 and Bifidobacterium lactis HN019 in BALB/c mice. Int J Food Microbiol 56(1):87–96
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kalkan, S., Erginkaya, Z., Turhan, E.Ü., Konuray, G. (2019). Assessment of the Risk of Probiotics in Terms of the Food Safety and Human Health. In: Malik, A., Erginkaya, Z., Erten, H. (eds) Health and Safety Aspects of Food Processing Technologies. Springer, Cham. https://doi.org/10.1007/978-3-030-24903-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-24903-8_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-24902-1
Online ISBN: 978-3-030-24903-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)